FilingReader Intelligence

Hualan Biological completes restricted stock repurchase and cancellation

May 20, 2025 at 05:21 PM UTCBy FilingReader AI

Hualan Biological Engineering (SZSE:002007) announced the completion of the repurchase and cancellation of restricted shares related to its 2023 restricted stock incentive plan. This involved 1,324,260 shares from 83 incentive recipients, representing 0.0724% of the company's total shares before the cancellation. The repurchase price was CNY 10.59 per share. The company has completed the necessary procedures with the Shenzhen branch of China Securities Depository and Clearing Corporation, reducing the total share capital from 1,828,780,926 shares to 1,827,456,666 shares. The total repurchase amount paid was CNY 14,023,913.40, funded by the company's own capital. The cancellation was triggered by unmet performance targets for the second vesting period of the 2023 plan. Hualan Biological will proceed with the necessary industrial and commercial registration changes. The board states that the repurchase does not have a material impact on the company's financial situation or operations.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002007Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Hualan Biological Engineering publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →